{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T18:21:00Z","timestamp":1770488460493,"version":"3.49.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajkd.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Kidney Diseases"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1053\/j.ajkd.2016.11.008","type":"journal-article","created":{"date-parts":[[2016,12,24]],"date-time":"2016-12-24T16:15:43Z","timestamp":1482596143000},"page":"30-37","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Intraperitoneal Vancomycin Plus Either Oral Moxifloxacin or Intraperitoneal Ceftazidime for the Treatment of Peritoneal Dialysis\u2212Related Peritonitis: A Randomized Controlled Pilot\u00a0Study"],"prefix":"10.1053","volume":"70","author":[{"given":"Rong","family":"Xu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhikai","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhen","family":"Qu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xue","family":"Tian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David W.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1053\/j.ajkd.2016.11.008_bib1","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1681\/ASN.2011060607","article-title":"Global trends in rates of peritoneal dialysis","volume":"23","author":"Jain","year":"2012","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"4","key":"10.1053\/j.ajkd.2016.11.008_bib2","doi-asserted-by":"crossref","first-page":"393","DOI":"10.3747\/pdi.2010.00049","article-title":"Peritoneal dialysis-related infections recommendations: 2010 update","volume":"30","author":"Li","year":"2010","journal-title":"Perit Dial Int"},{"issue":"5","key":"10.1053\/j.ajkd.2016.11.008_bib3","doi-asserted-by":"crossref","first-page":"481","DOI":"10.3747\/pdi.2016.00078","article-title":"ISPD peritonitis recommendations: 2016 update on prevention and treatment","volume":"9-10;36","author":"Li","year":"2016","journal-title":"Perit Dial Int"},{"issue":"5","key":"10.1053\/j.ajkd.2016.11.008_bib4","doi-asserted-by":"crossref","first-page":"565","DOI":"10.3747\/pdi.2010.00096","article-title":"Patient and physician predictors of peritoneal dialysis technique failure: a population based, retrospective cohort study","volume":"31","author":"Chidambaram","year":"2011","journal-title":"Perit Dial Int"},{"issue":"11","key":"10.1053\/j.ajkd.2016.11.008_bib5","doi-asserted-by":"crossref","first-page":"4173","DOI":"10.1093\/ndt\/gfs361","article-title":"Socio-economic status and incidence of renal replacement therapy: a registry study of Australian patients","volume":"27","author":"Grace","year":"2012","journal-title":"Nephrol Dial Transplant"},{"issue":"8","key":"10.1053\/j.ajkd.2016.11.008_bib6","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.2215\/CJN.11431210","article-title":"Geographic and educational factors and risk of the first peritonitis episode in Brazilian Peritoneal Dialysis study (BRAZPD) patients","volume":"6","author":"Martin","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1053\/j.ajkd.2016.11.008_bib7","doi-asserted-by":"crossref","first-page":"S165","DOI":"10.1038\/sj.ki.5002619","article-title":"Dialysis Outcomes in Colombia (DOC) study: a comparison of patient survival on peritoneal dialysis vs hemodialysis in Colombia","volume":"108","author":"Sanabria","year":"2008","journal-title":"Kidney Int Suppl"},{"issue":"2","key":"10.1053\/j.ajkd.2016.11.008_bib8","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1177\/089686089001000202","article-title":"Newer quinolones in the treatment of continuous ambulatory peritoneal dialysis (CAPD) related infections","volume":"10","author":"Nikolaidis","year":"1990","journal-title":"Perit Dial Int"},{"issue":"2","key":"10.1053\/j.ajkd.2016.11.008_bib9","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0272-6386(12)80513-0","article-title":"A\u00a0randomized prospective trial of three different regimens of treatment of peritonitis in patients on continuous ambulatory peritoneal dialysis","volume":"15","author":"Chan","year":"1990","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"10.1053\/j.ajkd.2016.11.008_bib10","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1177\/089686089101100107","article-title":"A\u00a0randomised prospective comparison of oral ofloxacin and intraperitoneal vancomycin plus aztreonam in the treatment of bacterial peritonitis complicating continuous ambulatory peritoneal dialysis (CAPD)","volume":"11","author":"Cheng","year":"1991","journal-title":"Perit Dial Int"},{"issue":"suppl F","key":"10.1053\/j.ajkd.2016.11.008_bib11","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1093\/jac\/26.suppl_F.73","article-title":"A\u00a0comparison between oral ciprofloxacin and intra-peritoneal vancomycin and gentamicin in the treatment of CAPD peritonitis","volume":"26","author":"Bennett-Jones","year":"1990","journal-title":"J\u00a0Antimicrob Chemother"},{"issue":"suppl F","key":"10.1053\/j.ajkd.2016.11.008_bib12","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1093\/jac\/26.suppl_F.63","article-title":"A\u00a0comparison between oral ciprofloxacin and intraperitoneal vancomycin and netilmicin in CAPD peritonitis","volume":"26","author":"Tapson","year":"1990","journal-title":"J\u00a0Antimicrob Chemother"},{"issue":"suppl 2","key":"10.1053\/j.ajkd.2016.11.008_bib13","doi-asserted-by":"crossref","first-page":"S351","DOI":"10.1177\/089686089301302S88","article-title":"A\u00a0randomized prospective comparison of oral versus intraperitoneal ciprofloxacin as the primary treatment of peritonitis complicating continuous ambulatory peritoneal dialysis","volume":"13","author":"Cheng","year":"1993","journal-title":"Perit Dial Int"},{"issue":"6","key":"10.1053\/j.ajkd.2016.11.008_bib14","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1111\/j.1440-1797.1997.tb00266.x","article-title":"A\u00a0randomized prospective comparison of oral versus intraperitoneal ofloxacin as the primary treatment of CAPD peritonitis","volume":"3","author":"Ignatius","year":"1997","journal-title":"Nephrology (Carlton)"},{"issue":"1","key":"10.1053\/j.ajkd.2016.11.008_bib15","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1177\/089686080702700113","article-title":"Ciprofloxacin and cefazolin as a combination for empirical initial therapy of peritoneal dialysis-related peritonitis: five-year follow-up","volume":"27","author":"Lima","year":"2007","journal-title":"Perit Dial Int"},{"key":"10.1053\/j.ajkd.2016.11.008_bib16","first-page":"213","article-title":"Once-daily intraperitoneal cefazolin and oral ciprofloxacin as empiric therapy for the treatment of peritonitis","volume":"15","author":"Troidle","year":"1999","journal-title":"Adv Perit Dial"},{"issue":"suppl 2","key":"10.1053\/j.ajkd.2016.11.008_bib17","doi-asserted-by":"crossref","first-page":"S348","DOI":"10.1177\/089686089301302S87","article-title":"Intraperitoneal vancomycin\/oral pefloxacin versus intraperitoneal vancomycin\/gentamicin in the treatment of continuous ambulatory peritoneal dialysis peritonitis","volume":"13","author":"Lye","year":"1993","journal-title":"Perit Dial Int"},{"issue":"1","key":"10.1053\/j.ajkd.2016.11.008_bib18","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1177\/089686089301300112","article-title":"Single-dose intraperitoneal vancomycin and oral ciprofloxacin for the treatment of peritonitis in CAPD patients: preliminary report","volume":"13","author":"Nye","year":"1993","journal-title":"Perit Dial Int"},{"issue":"2","key":"10.1053\/j.ajkd.2016.11.008_bib19","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1177\/089686089601600216","article-title":"IV vancomycin-oral ciprofloxacin: a safe and efficient therapeutic protocol for CAPD peritonitis (preliminary report)","volume":"16","author":"Goffin","year":"1996","journal-title":"Perit Dial Int"},{"issue":"6","key":"10.1053\/j.ajkd.2016.11.008_bib20","first-page":"391","article-title":"Oral ciprofloxacin to treat bacterial peritonitis associated with peritoneal dialysis","volume":"48","author":"Goffin","year":"1997","journal-title":"Clin Nephrol"},{"issue":"4","key":"10.1053\/j.ajkd.2016.11.008_bib21","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1177\/089686089801800404","article-title":"A\u00a0randomized prospective comparison of oral levofloxacin plus intraperitoneal (IP) vancomycin and IP netromycin plus IP vancomycin as primary treatment of peritonitis complicating CAPD","volume":"18","author":"Cheng","year":"1998","journal-title":"Perit Dial Int"},{"issue":"6","key":"10.1053\/j.ajkd.2016.11.008_bib22","doi-asserted-by":"crossref","first-page":"e17","DOI":"10.2165\/11599800-000000000-00000","article-title":"Essentials for selecting antimicrobial therapy for intra-abdominal infections","volume":"72","author":"Blot","year":"2012","journal-title":"Drugs"},{"issue":"suppl 4","key":"10.1053\/j.ajkd.2016.11.008_bib23","doi-asserted-by":"crossref","first-page":"S55","DOI":"10.1016\/S0924-8579(09)70569-2","article-title":"New antibiotics: optimal use in current clinical practice","volume":"34","author":"Karageorgopoulos","year":"2009","journal-title":"Int J Antimicrob Agents"},{"issue":"10","key":"10.1053\/j.ajkd.2016.11.008_bib24","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1517\/14656566.9.10.1735","article-title":"A\u00a0pharmacoeconomic review of the management of respiratory tract infections with moxifloxacin","volume":"9","author":"Simoens","year":"2008","journal-title":"Expert Opin Pharmacother"},{"issue":"6","key":"10.1053\/j.ajkd.2016.11.008_bib25","doi-asserted-by":"crossref","first-page":"437","DOI":"10.2165\/00151829-200605060-00009","article-title":"A\u00a0review of new fluoroquinolones: focus on their use in respiratory tract infections","volume":"5","author":"Zhanel","year":"2006","journal-title":"Treat Respir Med"},{"issue":"4","key":"10.1053\/j.ajkd.2016.11.008_bib26","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1053\/j.ajkd.2009.04.032","article-title":"Recurrent and relapsing peritonitis: causative organisms and response to treatment","volume":"54","author":"Szeto","year":"2009","journal-title":"Am J Kidney Dis"},{"issue":"5","key":"10.1053\/j.ajkd.2016.11.008_bib27","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1111\/j.1523-1755.2005.00700.x","article-title":"Cefazolin plus netilmicin versus cefazolin plus ceftazidime for treating CAPD peritonitis: effect on residual renal function","volume":"68","author":"Lui","year":"2005","journal-title":"Kidney Int"},{"issue":"9","key":"10.1053\/j.ajkd.2016.11.008_bib28","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1681\/ASN.2013091028","article-title":"Meta-analysis of methicillin-resistant Staphylococcus aureus colonization and risk of infection in dialysis patients","volume":"25","author":"Zacharioudakis","year":"2014","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"9","key":"10.1053\/j.ajkd.2016.11.008_bib29","doi-asserted-by":"crossref","first-page":"e0135969","DOI":"10.1371\/journal.pone.0135969","article-title":"Microbiological surveillance of peritoneal dialysis associated peritonitis: antimicrobial susceptibility profiles of a referral center in Germany over 32 years","volume":"10","author":"Kitterer","year":"2015","journal-title":"PLoS One"},{"issue":"6","key":"10.1053\/j.ajkd.2016.11.008_bib30","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1046\/j.1525-139X.2003.16095.x","article-title":"Continuous peritoneal dialysis-associated peritonitis: a review and current concepts","volume":"16","author":"Troidle","year":"2003","journal-title":"Semin Dial"}],"container-title":["American Journal of Kidney Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638616306382?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638616306382?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T02:55:58Z","timestamp":1759460158000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272638616306382"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,7]]}},"alternative-id":["S0272638616306382"],"URL":"https:\/\/doi.org\/10.1053\/j.ajkd.2016.11.008","relation":{},"ISSN":["0272-6386"],"issn-type":[{"value":"0272-6386","type":"print"}],"subject":[],"published":{"date-parts":[[2017,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intraperitoneal Vancomycin Plus Either Oral Moxifloxacin or Intraperitoneal Ceftazidime for the Treatment of Peritoneal Dialysis\u2212Related Peritonitis: A Randomized Controlled Pilot\u00a0Study","name":"articletitle","label":"Article Title"},{"value":"American Journal of Kidney Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.ajkd.2016.11.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 by the National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}